Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
The pharmaceutical industry bolstered its lobbying spending in the first three months of 2024 compared with the same period in 2023, according to newly filed disclosures, POLITICO’s Megan R. Wilson reports.
- Simplified Text
-
Pharmaceutical industry increased lobbying spending Q1 2024 compared to Q1 2023
- Confidence Score
- 0.900
- Claim Maker
- Megan R. Wilson
- Context Type
- News Article
- Context Details
-
{ "date": "2024-04-24", "topic": "Pharmaceutical Lobbying", "source": "Newly filed disclosures", "reporter": "Megan R. Wilson", "time_period": "First three months of 2024", "comparison_period": "Same period in 2023" } - Subject Tags
- UUID
- 9fdb00f9-ac45-4a37-8dd8-2653ebae26a1
- Vector Index
- ✗ No vector
- Created
- September 11, 2025 at 10:27 PM (22 hours ago)
- Last Updated
- September 11, 2025 at 10:27 PM (22 hours ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
51
claims
🔥
22 hours ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
Pharmaceutical industry lobbying spending surged in Q1 2024. Increased spending focuses on PBM reform and other congressional issues. This follows recent government funding bill negotiations.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.